Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-050057

Director sold 14,407 shares at $45.16 ($650,587)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Prokupets Elena Director 2021-08-03 Sale −14,407 $45.16 $650,587 88,574 I
Open-market sales · 14,407 sh · avg $45.16 · $650,587
Loading xslF345X03/doc4.xml…